Table 2.
Pathophysiological roles of FGFs in the postnatal mouse heart.
| Function | Heart phenotype | |
|---|---|---|
| PARACRINE SIGNAL | ||
| FGF2 | Loss-of-function | Protection against induced cardiac hypertrophy and fibrosis Promotion of cardiac ischemia-reperfusion injury |
| Gain-of-function | Promotion of cardiac hypertrophy | |
| FGF9 | Gain-of-function | Improvement in heart function |
| Gain-of-function | Protection against heart injury | |
| FGF10 | Gain-of-function | Protection against heart injury |
| Gain-of-function | Promotion of cardiomyocyte proliferation | |
| FGF16 | Loss-of-function | Promotion of induced cardiac hypertrophy and fibrosis |
| FGF21 | Loss-of-function | Promotion of induced cardiac hypertrophy and inflammation |
| ENDOCRINE SIGNAL | ||
| FGF21 | Gain-of-function | Protection against cardiac dysfunction and inflammation |
| Loss-of-function | Promotion of cardiac dysfunction and inflammation | |